Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04376034 · ClinicalTrials.gov registry record · Phase 3
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
A Phase 3 study of Covid19 and Coronavirus, sponsored by West Virginia University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04376034 is a Phase 3 study of Covid19 and Coronavirus that is actively recruiting participants, run by West Virginia University. The registered enrollment target is 240 participants, below the 2,700-participant average among 94 other Covid19 trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04376034, a Phase 3 study of Covid19 and Coronavirus, is actively recruiting participants, sponsored by West Virginia University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study, involving contacting potential plasma donors and the use of their plasma to help fight off infections of those suffering from COVID19 in accordance to collection guidelines for plasma and FDA IND requirement. This study will include up to 240 participants potentially receiving convalescent plasma and up to 1000 potential donors. There are 3 basic arms to the study: mild, moderate and severe/critical severity. All 3 severity groups are eligible for enrollment, but mild severity will not be given plasma unless there is progression. Moderate severity will given up to 1 unit of plasma and severe/critical severity up to 2 units. There is no placebo group, however given the excepted issues of shortages of plasma, intention to treat will be used for analysis.
Conditions Studied
Interventions
- OTHER Standard of Care
- BIOLOGICAL Convalescent Plasma 1 Unit
- BIOLOGICAL Convalescent Plasma 2 Units
Study Locations (1)
West Virginia
- WVU Medicine - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-04-16 |
| Est. Completion | 2021-03-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04376034
The ClinicalTrials.gov registry entry for NCT04376034 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,700-participant average among 94 other Covid19 trials with a reported enrollment target (91% lower). The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Covid19 appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT04376034 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT04376034 about?
NCT04376034 is a clinical study titled "Convalescent Plasma Collection and Treatment in Pediatrics and Adults". This is a prospective study, involving contacting potential plasma donors and the use of their plasma to help fight off infections of those suffering from COVID19 in accordance to collection guidelines for plasma and FDA IND requirement. This study will include up to 240 participants potentially rec...
What is the current status of trial NCT04376034?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2020-04-16. Estimated completion is 2021-03-30.
What conditions does trial NCT04376034 study?
This clinical trial studies the following conditions: Covid19, Coronavirus, Coronavirus Infection, Virus Diseases, RNA Virus Infections.
What interventions are being tested in trial NCT04376034?
The interventions under investigation include: Standard of Care (OTHER), Convalescent Plasma 1 Unit (BIOLOGICAL), Convalescent Plasma 2 Units (BIOLOGICAL).
Who is sponsoring clinical trial NCT04376034?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04376034 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2
COMPLETED · Phase 3
-
Aggrenox To Treat Acute Covid-19
COMPLETED · Phase 3
-
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
COMPLETED · Phase 3
-
Contrast Enhanced Ultrasound in COVID-19
COMPLETED · Phase 3
-
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.